Cambridge, UK – Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Cancer Research UK Manchester Institute (CRUK MI), has licensed Flare for fresh insights into structure-based drug design. “Putting easy-to use and visually driven structure-based design software in the hands of our medicinal chemists will empower them to deliver the next generation [...]

Heidelberg and Dortmund, Germany – The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify biomarkers that predict therapeutic response and the incidence of immune-related adverse events (irAEs) in urothelial carcinoma patients treated with checkpoint inhibitors. In recent years, checkpoint inhibitors have [...]

SAN DIEGO and AUCKLAND, New Zealand -- Ubiquitome Limited today announced the launch of the Liberty16 at the American Society of Human Genetics conference, the latest product in its range of mobile real-time PCR systems. Designed to give users access to mobile, cutting-edge DNA testing, the Liberty16 offers DNA quantitation capability whenever and wherever it's needed. The Liberty16 mobile personal genomics [...]

BGI, Gencove Team Up To Provide Unique Whole Genome NGS Solutions To Rival Genotyping Arrays   Cambridge, MA and New York, October 18, 2018 – BGI Americas, a genomics services leader, and Gencove, a leading genomics technology company, announced today that they have entered into an agreement to offer a new low-pass sequencing service to [...]

Effort Designed to Safely and Efficiently Speed Drug Candidates into the Clinic Geneva, Switzerland – Selexis SA and Berkeley Lights, Inc. today announced a collaboration around the acquisition of Berkeley Lights’ Beacon® optofluidic platform. The partners will leverage the technology to accelerate cell line development (CLD) with the Selexis SUREtechnology Platform™. Selexis scientists have extensively evaluated the Beacon [...]

Partnership will improve access to critical literature content and accelerate patient diagnosis OAKLAND, Calif. & ANN ARBOR, Mich.--Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant [...]

New partnership enables pharmaceutical and healthcare delivery companies with graph-based analytics capabilities for actionable insights BOSTON Cambridge Semantics, the leading provider of an enterprise data fabric, and Symbotix, a healthcare technology innovation and consultancy group, today announced a partnership that aims to help solve the most challenging data problems of modern healthcare enterprises. Today’s healthcare organizations [...]

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that Amgen (NASDAQ:AMGN) has announced an equity investment of £50 million into portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore” or “the Company”).   The investment will be effected through the purchase of £50 million of existing ordinary [...]

Porvair Sciences new UltraVap Mistral XT 100 allows for the first time, full automated dry down of organic solvent-based samples in tubes up to 100mm in length. The UltraVap Mistral XT 100 is Porvair Sciences latest fully robot compatible nitrogen blow-down evaporator, suitable for integration adjacent to most leading laboratory liquid handling robots. Designed with the demands of [...]

- Strategic Deal Extends and Diversifies Company's Footprint in Life Science Research- Expands Luminex's Flow-based Instrument Offering Into Cellular Analysis with Acquisition of Amnis and Guava Branded Instruments- Transaction Expected to Close by End of 2018 AUSTIN, Texas, Oct. 18, 2018 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has signed a definitive agreement to acquire [...]